Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.43 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.43 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.42 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.42 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.41 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.41 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.41 |
| ▸ | GSR | P00390 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9716842 | 1.00 | SLC6A5 (0.47) | SLC6A5FFAR1FFAR4GRIK1GRIK2 | |
| SCHEMBL2345422 | 1.00 | SLC6A5 (0.47) | SLC6A5FFAR1FFAR4GRIK1GRIK2 | |
| SCHEMBL1532640 | 1.00 | SLC6A5 (0.47) | SLC6A5FFAR1FFAR4GRIK1GRIK2 | |
| SCHEMBL9716734 | 1.00 | SLC6A5 (0.47) | SLC6A5FFAR1FFAR4GRIK1GRIK2 | |
| SCHEMBL1532638 | 1.00 | SLC6A5 (0.47) | SLC6A5FFAR1FFAR4GRIK1GRIK2 | |
| SCHEMBL9314956 | 1.00 | SLC6A5 (0.47) | SLC6A5FFAR1FFAR4GRIK1GRIK2 | |
| SCHEMBL9716836 | 1.00 | SLC6A5 (0.47) | SLC6A5FFAR1FFAR4GRIK1GRIK2 | |
| SCHEMBL9716728 | 1.00 | SLC6A5 (0.47) | SLC6A5FFAR1FFAR4GRIK1GRIK2 | |
| SCHEMBL9716750 | 1.00 | SLC6A5 (0.47) | SLC6A5FFAR1FFAR4GRIK1GRIK2 | |
| SCHEMBL21838291 | 1.00 | SLC6A5 (0.47) | SLC6A5FFAR1FFAR4GRIK1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114651014-A | IL-15 fusion peptides for the treatment of cancer | 前列腺癌研究中心 | 2022-06-21 | — | — | CN | claimed |
| EP-4110809-A1 | COMPOSITIONS AND METHODS | King's College London (GB) | 2023-01-04 | — | — | EP | disclosed |
| CN-114651014-A | IL-15 fusion peptides for the treatment of cancer | 前列腺癌研究中心 | 2022-06-21 | — | — | CN | disclosed |
| US-8647613-B2 | Drug carrier | JCR PHARMACEUTICALS CO., LTD. (JP) | 2014-02-11 | — | — | US | disclosed |
| EP-1219659-B1 | AMPHIPATHIC COMPOUND HAVING DENDRITIC STRUCTURE | UNIV WASEDA (JP) | 2010-07-28 | — | — | EP | disclosed |
| US-20090136443-A1 | Drug Carrier | OXGENIX CO., LTD. (JP) | 2009-05-28 | — | — | US | disclosed |
| US-6933352-B2 | Amphiphilic compounds having a dendritic branch structure | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2005-08-23 | — | — | US | disclosed |
| US-20020120096-A1 | Capable of stably fixing a water-soluble polymer onto a surface structure by taking advantage of intermolecular interaction, thereby enabling the water-soluble polymer to be carried thereon without giving any damage | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2002-08-29 | — | — | US | disclosed |
| EP-1219659-A1 | AMPHIPATHIC COMPOUND HAVING DENDRITIC STRUCTURE | Japan Science and Technology Corporation (JP) | 2002-07-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090136443-A1 | Drug Carrier | ABCB11, SLC47A1, SLC47A2 | SLC6A5 504/4885FFAR1 360/4885FFAR4 472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.